BioSpace News Archive

FDA

U.S. FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder

VistaGen’s PH94B is the first drug candidate to be granted U.S. FDA Fast Track designation for treatment of social anxiety disorder

December 10, 2019
·
7 min read
Biotech Beach

Opioid Overdose Risk Is High After Medical Treatment Ends, Study Finds

Researchers at Columbia University Discover Link Between Opioid Overdose and Treatment with Buprenorphine.

December 10, 2019
·
3 min read
FDA

Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis

U.S. Food and Drug Administration (FDA) has granted Fast Track designation for lebrikizumab, its novel, investigational treatment being evaluated for patients with moderate-to-severe atopic dermatitis.

December 10, 2019
·
7 min read
BioMidwest

Daavlin Partners with HealthLens to Increase Phototherapy Access for Patients

New Teledermatology Service Designed to Provide Quick Diagnosis and Treatment to Patients with Psoriasis, Vitiligo or Eczema

December 10, 2019
·
3 min read
Policy

CMS Renews ACHC Deeming Authority for Hospice Accreditation

Accreditation Commission for Health Care reaffirms its status as a national leader in hospice accreditation with the recent renewal of its recognition as an approved accreditor for Medicare providers.

December 10, 2019
·
2 min read
Business

PatientTrak Joins the Epic App Orchard

New integration allows Epic users to send text messages during care

December 10, 2019
·
2 min read
Business

Landrace Bioscience Announces New Supply Chain and Product Development Services Agreement with Abacus Health Products

The dual-pronged partnership will leverage Landrace’s industry-leading product development capabilities to create and supply a catalog of consumer goods.

December 10, 2019
·
3 min read
Deals

ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock and Concurrent $3 Million Private Placement of Common Stock to Pfizer

ContraFect Corporation announced the pricing of its underwritten public offering of 37,150,000 shares of its common stock at a public offering price of $0.27 per share.

December 10, 2019
·
6 min read
Business

Eitan Group Signs Service Agreement With Integrated Medical Systems

Eitan Group, a global leader in advanced infusion therapy solutions across the care continuum, today announced a service partnership with Integrated Medical Systems, Inc. (IMS), a leading national distributor within the alternate site market

December 10, 2019
·
2 min read
Biotech Bay

Verantos Receives a Grant from the National Institutes of Health (NIH) to Fund Advanced Clinical Phenotyping in Real World Evidence Studies

The grant supports advanced scientific efforts by Verantos to define the clinical phenotype, a detailed view of patient characteristics required for RWE studies.

December 10, 2019
·
2 min read